A TI-RADS 3 result on your thyroid ultrasound can feel worrying, especially when you see the word “suspicious” attached to it. But TR3 is classified as only mildly suspicious, and the numbers behind it are reassuring. This article puts it in perspective.
The Short Answer: Usually Not
TI-RADS 3 (TR3) has an estimated malignancy risk of approximately 4.8 percent. That means roughly 95 out of 100 TR3 nodules are benign. It is the lowest category that carries any follow-up recommendation at all, and for most people with small TR3 nodules, nothing needs to be done.
Why It Says “Mildly Suspicious”
A nodule reaches TR3 by scoring exactly 3 points across the five ultrasound features. That usually comes from a single modest finding, such as a solid composition (2 points) combined with isoechoic echogenicity (1 point) and nothing else concerning. One step lower and it would be TR2 (not suspicious, no follow-up). One step higher and it would be TR4 (moderately suspicious).
TR3 is the category where the TI-RADS system starts paying attention, but only for larger nodules.
When TR3 Needs Action
For TR3, the size thresholds are the most generous of any suspicious category:
- 2.5 cm or larger — biopsy is recommended
- 1.5 to 2.4 cm — follow-up ultrasound at 1, 3, and 5 years
- Under 1.5 cm — no biopsy, no follow-up
Most TR3 nodules are small enough to fall below any action threshold. Check yours with the TI-RADS calculator.
Comparing TR3 to Other Categories
To put TR3 in context:
| Category | Malignancy risk | Biopsy threshold |
|---|---|---|
| TR2 | ~1.5% | No biopsy ever |
| TR3 | ~4.8% | 2.5 cm |
| TR4 | ~9.1% | 1.5 cm |
| TR5 | ~35% | 1.0 cm |
TR3 is much closer to TR2 (not suspicious) than to TR4 or TR5. The jump in concern happens at TR4, not TR3.
What You Should Do
If your nodule is under 1.5 cm, you likely need nothing. If it falls in the 1.5 to 2.4 cm follow-up range, your doctor will schedule periodic ultrasounds to watch for any changes. If it reaches 2.5 cm, a simple outpatient biopsy provides a definitive answer.
For the complete category breakdown, see our TI-RADS 3 guide and what your TI-RADS score means.
Frequently Asked Questions
Is TI-RADS 3 cancer?
Almost never. Only about 5 out of 100 TR3 nodules are malignant. The vast majority are benign and need no treatment.
Does TR3 need a biopsy?
Only if the nodule is 2.5 cm or larger. Smaller TR3 nodules are either monitored or need no action at all.
Can a TR3 nodule become TR4?
A nodule’s category can change on follow-up if its ultrasound features change. This is uncommon but is exactly what follow-up scans are designed to detect.